Cargando…
Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned
International regulatory authorities and funders require that research be disseminated promptly and appropriately to all involved stakeholders. However, following completion of clinical trials participants often either do not receive any feedback or materials provided are not appropriate for the con...
Autores principales: | Degaga, Tamiru S., Weston, Sophie, Tego, Tedla T., Abate, Dagimawie T., Aseffa, Ashenafi, Wayessa, Adugna, Price, Ric N., Hailu, Asrat, Thriemer, Kamala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282093/ https://www.ncbi.nlm.nih.gov/pubmed/32513176 http://dx.doi.org/10.1186/s12936-020-03279-5 |
Ejemplares similares
-
Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas—a randomized controlled trial (PRIMA)
por: Thriemer, Kamala, et al.
Publicado: (2022) -
Chloroquine efficacy for Plasmodium vivax malaria treatment in southern Ethiopia
por: Getachew, Sisay, et al.
Publicado: (2015) -
Adapting international clinical trials during COVID-19 and beyond
por: Thriemer, Kamala, et al.
Publicado: (2023) -
Variation in Complexity of Infection and Transmission Stability between Neighbouring Populations of Plasmodium vivax in Southern Ethiopia
por: Getachew, Sisay, et al.
Publicado: (2015) -
Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria
por: Ley, Benedikt, et al.
Publicado: (2022)